DAVID REICHEL: Open Payments
NPI 1508867458 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 16 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $353 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Lilly USA, LLC | 4 | $74 |
| Novo Nordisk Inc | 2 | $54 |
| Exact Sciences Corporation | 2 | $46 |
| Astellas Pharma US Inc | 2 | $36 |
| PFIZER INC. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $14 |
Products named: LEQVIO, MOUNJARO, The Cologuard Plus Collection Kit, Veozah, Wegovy, Ozempic, PREVNAR 20, JARDIANCE.
Industry payments across FL — which companies pay providers there.
